GLENOIDIMPLANTAT

European patent · EP3958796 · In force

Register entry

Publication number
EP3958796
Application number
EP20794902
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 24, 2020
Published
Mar 2, 2022
Granted
Feb 14, 2024
Protection ends at the latest
Apr 23, 2040
Next annual fee due
Apr 30, 2027
IPC classes
A61F 2/40 (2006.01)
A61F 2/30 (2006.01)
Priority
US 201962838633 P 25.04.2019
PCT application
PCT/US2020/029947 24.04.2020
PCT publication
WO2020/219973 29.10.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. Dec 25, 2024

    Change

    Published in Swissreg on 25.12.2024

  4. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  5. Apr 9, 2024

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 09.04.2024

  6. Feb 14, 2024

    Granted

    Published in Swissreg on 14.02.2024

Parties

Holder

Encore Medical, L.P. (D/B/A DJO Surgical)

9800 Metric Boulevard, Austin, TX 78758, US

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

SRIRAM, Shreyas

Sammamish, Washington 98075, US

HAMANN, Catherine, Ann

Chester, New York 10918, US

ACKLEY, Katherine, Victoria

Falls Church, Virginia 22044, US

AXELSON, Stuart, L.

Succasunna, New Jersey 07876, US

TRIBBLE, Grant, Lieder

Hagerstown, Maryland 21742, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.